ImmunoBiome Stock

ImmunoBiome is a biotech company developing microbiome therapeutics to treat incurable diseases like autoimmune diseases.

Sign up today and learn more about ImmunoBiome Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About ImmunoBiome Stock

ImmunoBiome aims to develop microbiome therapeutics to treat incurable diseases like cancer and autoimmune diseases based on our top-notch immunology, bioinformatics, and microbiome-oriented basic research.

Funding History

November 2019$2.3M
September 2020$6.9M
September 2021$18.0M

Management

CFO/COO

Donghoon Lee

CEO

Sin-Hyeog Im

Press

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo